Hydramine and Sodium ascorbate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hydramine (diphenhydramine hydrochloride) and Sodium ascorbate (vitamin c (ascorbic acid)). Common drug interactions include constipation among females and drug dependence among males.

The phase IV clinical study analyzes what interactions people have when they take Hydramine and Sodium ascorbate. It is created by eHealthMe based on reports of 58 people who take the same drugs from the FDA, and is updated regularly.

What is Hydramine?

Hydramine has active ingredients of diphenhydramine hydrochloride. It is often used in insomnia. eHealthMe is studying from 114,900 Hydramine users. Check the latest studies of Hydramine.

What is Sodium ascorbate?

Sodium ascorbate has active ingredients of vitamin c (ascorbic acid). eHealthMe is studying from 321 Sodium ascorbate users. Check the latest studies of Sodium ascorbate.



On Aug, 12, 2026

58 people who take Hydramine and Sodium ascorbate together, and have interactions are studied.

Hydramine and Sodium ascorbate drug interactions.

What are the common drug interactions of Hydramine and Sodium Ascorbate, by gender? *:

female:

  1. Constipation
  2. Erythema (redness of the skin)
  3. Drug ineffective
  4. Infusion related reaction
  5. Pyrexia (fever)
  6. Fatigue (feeling of tiredness)
  7. Hepatic enzyme increased
  8. Asthma
  9. Back pain
  10. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)

male:

  1. Drug dependence
  2. Respiratory depression (respiration has a rate below 12 breaths)
  3. Victim of child abuse
  4. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  5. Gastrointestinal infection (infection of stomach and intestine)
  6. Pneumonia
  7. Sepsis (a severe blood infection that can lead to organ failure and death)
  8. Respiratory failure (inadequate gas exchange by the respiratory system)

What are the common drug interactions of Hydramine and Sodium Ascorbate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Drug dependence
  2. Respiratory depression (respiration has a rate below 12 breaths)
  3. Victim of child abuse

20-29:

n/a

30-39:

  1. Thrombocytopenia (decrease of platelets in blood)
  2. Upper respiratory tract infection
  3. Asthma
  4. Back pain
  5. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  6. Coeliac disease (simple food intolerance)
  7. Constipation
  8. Drug hypersensitivity
  9. Drug ineffective
  10. Drug intolerance (drug sensitivity)

40-49:

n/a

50-59:

  1. Asthma
  2. Back pain
  3. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  4. Coeliac disease (simple food intolerance)
  5. Constipation
  6. Drug hypersensitivity
  7. Erythema (redness of the skin)
  8. Fatigue (feeling of tiredness)
  9. Fluid retention (an abnormal accumulation of fluid in the blood)
  10. Food allergy

60+:

  1. Abdominal pain
  2. Pain
  3. Procedural pain
  4. Pyrexia (fever)
  5. Weight decreased
  6. Anaemia (lack of blood)
  7. Colitis (inflammation of colon)
  8. Colitis ulcerative (inflammation of colon with ulcer)
  9. Constipation
  10. Erythema (redness of the skin)

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 33 people, 56.90%
  2. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 31 people, 53.45%
  3. Herpes Zoster: 20 people, 34.48%
  4. Pain: 19 people, 32.76%
  5. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 16 people, 27.59%
  6. Allergies: 13 people, 22.41%
  7. Asthma: 12 people, 20.69%
  8. Nausea (feeling of having an urge to vomit): 9 people, 15.52%
  9. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 5 people, 8.62%
  10. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 5.17%

* Approximation only. Some reports may have incomplete information.

Do you take Hydramine and Sodium ascorbate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Hydramine and Sodium ascorbate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Hydramine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Sodium ascorbate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydramine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sodium ascorbate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on diphenhydramine hydrochloride and vitamin c (ascorbic acid) (the active ingredients of Hydramine and Sodium ascorbate, respectively), and Hydramine and Sodium ascorbate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: